Lucid Genomics provides a long-read genome interpretation platform designed to transform raw sequencing data into clinically actionable insights. The solution integrates variant calling, prioritization, interpretation, and reporting into a single system, addressing the fragmented nature of current tools. Specifically targeting rare diseases and hereditary disorders, it supports both clinicians and researchers by enabling the detection of structural variants, repeat expansions, and methylation patterns missed by short-read technologies. Built on science from the Max Planck Institute, the platform aims to improve molecular diagnosis rates and streamline genomic workflows through AI-driven analysis and secure deployment options.